Zhang, Wuji http://orcid.org/0000-0001-7460-4956
Kedzierski, Lukasz http://orcid.org/0000-0003-0203-1057
Chua, Brendon Y.
Mayo, Mark
Lonzi, Claire
Rigas, Vanessa
Middleton, Bianca F.
McQuilten, Hayley A. http://orcid.org/0000-0002-7089-5300
Rowntree, Louise C.
Allen, Lilith F.
Purcell, Ruth A. http://orcid.org/0000-0001-6378-5114
Tan, Hyon-Xhi http://orcid.org/0000-0003-1064-3934
Petersen, Jan
Chaurasia, Priyanka http://orcid.org/0000-0002-3755-159X
Mordant, Francesca http://orcid.org/0000-0002-3754-2642
Pogorelyy, Mikhail V.
Minervina, Anastasia A.
Crawford, Jeremy Chase http://orcid.org/0000-0003-4096-6048
Perkins, Griffith B. http://orcid.org/0000-0001-8559-5872
Zhang, Eva
Gras, Stephanie http://orcid.org/0000-0001-7416-038X
Clemens, E. Bridie
Juno, Jennifer A. http://orcid.org/0000-0002-9072-1017
Audsley, Jennifer
Khoury, David S. http://orcid.org/0000-0002-2663-1551
Holmes, Natasha E.
Thevarajan, Irani
Subbarao, Kanta
Krammer, Florian http://orcid.org/0000-0003-4121-776X
Cheng, Allen C.
Davenport, Miles P. http://orcid.org/0000-0002-4751-1831
Grubor-Bauk, Branka
Coates, P. Toby
Christensen, Britt
Thomas, Paul G. http://orcid.org/0000-0001-7955-0256
Wheatley, Adam K. http://orcid.org/0000-0002-5593-9387
Kent, Stephen J. http://orcid.org/0000-0002-8539-4891
Rossjohn, Jamie http://orcid.org/0000-0002-2020-7522
Chung, Amy W. http://orcid.org/0000-0003-0020-9704
Boffa, John
Miller, Adrian
Lynar, Sarah
Nelson, Jane
Nguyen, Thi H. O. http://orcid.org/0000-0002-9294-7693
Davies, Jane http://orcid.org/0000-0002-3843-837X
Kedzierska, Katherine http://orcid.org/0000-0001-6141-335X
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Article History
Received: 29 September 2022
Accepted: 10 April 2023
First Online: 29 May 2023
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays and Newcastle disease virus-based SARS-CoV-2 vaccines that list F.K. as coinventor. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. F.K. has consulted for Merck and Pfizer (before 2020), and is currently consulting for Pfizer, CSL Seqirus and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2. H.A.M. is currently consulting for ENA Respiratory. P.T. is on the scientific advisory board of ImmunoScape and CytoAgents and has consulted for Johnson & Johnson. P.T. has received travel support and honoraria from Illumina and 10X Genomics and has patents related to TCR discovery and expression. The other authors declare no competing interests.